Belatacept Immunosuppression in High Risk Liver Transplant Recipients

被引：0
|
作者：
Masters, Brian M. [1 ,2 ]
Sparkes, Tracy M. [1 ,2 ]
Hanish, Steven I. [2 ]
Potosky, Darryn R. [2 ]
Hutson, William R. [2 ]
Barth, Rolf N. [2 ]
LaMattina, John C. [2 ]
机构：
[1] Univ Maryland, Med Ctr, Pharm, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Transplant, Baltimore, MD 21201 USA
来源：
TRANSPLANTATION | 2015年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-473
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [1] Clinical Safety of Belatacept Bridging Immunosuppression in Liver Transplant Recipients.
    Sparkes, T.
    Masters, B.
    Jason, M.
    Hanish, S.
    Ottmann, S.
    Klassen, D.
    Potosky, D.
    Hutson, W.
    Barth, R.
    LaMattina, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 711 - 711
  • [2] Clinical Safety of Belatacept Bridging Immunosuppression in Liver Transplant Recipients.
    Sparkes, T.
    Masters, B.
    Jason, M.
    Hanish, S.
    Ottmann, S.
    Klassen, D.
    Potosky, D.
    Hutson, W.
    Barth, R.
    LaMattina, J.
    TRANSPLANTATION, 2014, 98 : 711 - 711
  • [3] Belatacept Is Safe and Effective Bridging Immunosuppression in Liver Transplant Recipients with Renal Dysfunction
    LaMattina, John
    Jason, Mihaela
    Hanish, Steven
    Ottmann, Shane
    Klassen, David
    Potosky, Darryn
    Hutson, William
    Barth, Rolf
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 95 - 95
  • [4] Bridging Therapy With Belatacept in High MELD Liver Transplant Recipients
    Sparkes, T.
    Masters, B.
    Hanish, S.
    Potosky, D.
    Hutson, W.
    LaMattina, J.
    Barth, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [5] Renal Outcomes of High-Risk Kidney Transplant Recipients After Conversion to Belatacept-Based Immunosuppression
    Anders, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S847 - S848
  • [6] Early Conversion to Belatacept in High Risk Renal Transplant Recipients
    Santeusanio, A.
    Bhansali, A.
    Shapiro, R.
    Delaney, V.
    Florman, S.
    De Boccardo, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 686 - 686
  • [7] Conversion to a Belatacept Based Immunosuppression Regimen in Renal Transplant Recipients
    Paplaczyk, K.
    Cunningham, K.
    D'Agostino, C.
    Pinelli, D.
    Schulte, J.
    Shetty, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 439 - 440
  • [8] Belatacept Based Immunosuppression and Incidence of Proteinuria in Kidney Transplant Recipients
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [9] Maintenance Belatacept- Based Immunosuppression in Lung Transplant Recipients
    Shoemaker, C.
    Floyd, S.
    Mannem, H.
    Sharma, B.
    Weder, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1030 - S1031
  • [10] IMMUNOSUPPRESSION WITH SIROLIMUS INCREASES CARDIOVASCULAR RISK IN LIVER TRANSPLANT RECIPIENTS
    Doycheva, I. B.
    Couto, C. A.
    Gelape, C. L.
    Kish, J. K.
    Martin, P.
    Levy, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S82 - S82
12345